In the last week, the Trump administration has taken steps to fast-track reviews of psychedelics and widen access to some peptide injections — two types of medical interventions that scientists are still evaluating for safety and efficacy. The approach contrasts sharply with its stance on a different area of medicine backed by far more data: vaccines.